Caplans syndrome epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(14 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}
{{CMG}} {{AE}} {{SharmiB}}
{{Caplans syndrome}}
{{Caplans syndrome}}


==Overview==
==Overview==
The incidence of Caplan syndrome is 1 in 100,000 people but it is decreasing due to the reduction of exposure to coal, silica, and asbestos. Silica exposure has the most prevalence of Caplan syndrome.
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
* Caplan syndrome is very rare in the United States. [[Incidence]] is currently 1 in 100,000 people but is likely to fall as the coal mining industry declines.
 
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*[[Caplan syndrome]] is very rare in the United States. [[Incidence]] is currently 1 in 100,000 people but is likely to fall as the coal mining industry declines.<ref name="pmidPMID: 29763061.">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue=  | pages=  | pmid=PMID: 29763061. | doi= | pmc= | url= }} </ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.


===Prevalence===
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
*The [[prevalence]] of [[Caplan syndrome]] is estimated to be very low.<ref name="pmidPMID: 29763061.">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue= | pages= | pmid=PMID: 29763061. | doi= | pmc= | url= }} </ref>
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
* Most recent study showed the prevalence of [[Caplan syndrome]] n Japan is 0.75% and in the USA it is 0.89%. No recent study on the prevalence in Europe.<ref name="Benedek1973">{{cite journal|last1=Benedek|first1=Thomas G.|title=Rheumatoid pneumoconiosis|journal=The American Journal of Medicine|volume=55|issue=4|year=1973|pages=515–524|issn=00029343|doi=10.1016/0002-9343(73)90209-X}}</ref>
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
 
===case-fatality rate/Mortality rate===
 
*Mortality rate in Caplan syndrome is very low except in association with black lung caused by coal worker pneumoconiosis.<ref name="ShawCollins2015">{{cite journal|last1=Shaw|first1=Megan|last2=Collins|first2=Bridget F.|last3=Ho|first3=Lawrence A.|last4=Raghu|first4=Ganesh|title=Rheumatoid arthritis-associated lung disease|journal=European Respiratory Review|volume=24|issue=135|year=2015|pages=1–16|issn=0905-9180|doi=10.1183/09059180.00008014}}</ref>


===Age===
===Age===
*Patients of all age groups may develop [disease name].
 
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
* Aveerage age of first radiographic appearance of Caplan syndrome is 54 years. The age range is 41 to 64 years of age. <ref name="LindarsDavies1967">{{cite journal|last1=Lindars|first1=D. C.|last2=Davies|first2=D.|title=Rheumatoid pneumoconiosis: A study in colliery populations in the East Midlands coalfield|journal=Thorax|volume=22|issue=6|year=1967|pages=525–532|issn=0040-6376|doi=10.1136/thx.22.6.525}}</ref><ref name="AlayaBraham2018">{{cite journal|last1=Alaya|first1=Zeineb|last2=Braham|first2=Mouna|last3=Aissa|first3=Sana|last4=Kalboussi|first4=Houda|last5=Bouajina|first5=Elyès|title=A case of Caplan syndrome in a recently diagnosed patient with silicosis: A case report|journal=Radiology Case Reports|volume=13|issue=3|year=2018|pages=663–666|issn=19300433|doi=10.1016/j.radcr.2018.03.004}}</ref>
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
 
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
*There is no racial predilection to Caplan syndrome.
 
===Gender===
===Gender===
*[Disease name] affects men and women equally.
 
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
*There is no study available on gender.


===Region===
===Region===
*The majority of [disease name] cases are reported in [geographical region].


*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
*The majority of [[Caplan syndrome]] cases are reported 0.75% in Japan and 1.5% in the United States.<ref>{{cite journal|title=Rheumatoid Pneumoconiosis: A Comparative Study of Autopsy Cases between Japan and North America|journal=The Annals of Occupational Hygiene|year=2002|issn=1475-3162|doi=10.1093/annhyg/46.suppl_1.265}}</ref>
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]

Latest revision as of 02:13, 21 June 2021

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sharmi Biswas, M.B.B.S

Caplans syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Caplans syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Caplans syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Caplans syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Caplans syndrome epidemiology and demographics

CDC on Caplans syndrome epidemiology and demographics

Caplans syndrome epidemiology and demographics in the news

Blogs on Caplans syndrome epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Caplans syndrome epidemiology and demographics

Overview

The incidence of Caplan syndrome is 1 in 100,000 people but it is decreasing due to the reduction of exposure to coal, silica, and asbestos. Silica exposure has the most prevalence of Caplan syndrome.

Epidemiology and Demographics

Incidence

  • Caplan syndrome is very rare in the United States. Incidence is currently 1 in 100,000 people but is likely to fall as the coal mining industry declines.[1]

Prevalence

case-fatality rate/Mortality rate

  • Mortality rate in Caplan syndrome is very low except in association with black lung caused by coal worker pneumoconiosis.[3]

Age

  • Aveerage age of first radiographic appearance of Caplan syndrome is 54 years. The age range is 41 to 64 years of age. [4][5]

Race

  • There is no racial predilection to Caplan syndrome.

Gender

  • There is no study available on gender.

Region

  • The majority of Caplan syndrome cases are reported 0.75% in Japan and 1.5% in the United States.[6]

References

  1. ↑ 1.0 1.1 "StatPearls". 2021. PMID 29763061. PMID: 29763061. Check |pmid= value (help).
  2. ↑ Benedek, Thomas G. (1973). "Rheumatoid pneumoconiosis". The American Journal of Medicine. 55 (4): 515–524. doi:10.1016/0002-9343(73)90209-X. ISSN 0002-9343.
  3. ↑ Shaw, Megan; Collins, Bridget F.; Ho, Lawrence A.; Raghu, Ganesh (2015). "Rheumatoid arthritis-associated lung disease". European Respiratory Review. 24 (135): 1–16. doi:10.1183/09059180.00008014. ISSN 0905-9180.
  4. ↑ Lindars, D. C.; Davies, D. (1967). "Rheumatoid pneumoconiosis: A study in colliery populations in the East Midlands coalfield". Thorax. 22 (6): 525–532. doi:10.1136/thx.22.6.525. ISSN 0040-6376.
  5. ↑ Alaya, Zeineb; Braham, Mouna; Aissa, Sana; Kalboussi, Houda; Bouajina, Elyès (2018). "A case of Caplan syndrome in a recently diagnosed patient with silicosis: A case report". Radiology Case Reports. 13 (3): 663–666. doi:10.1016/j.radcr.2018.03.004. ISSN 1930-0433.
  6. ↑ "Rheumatoid Pneumoconiosis: A Comparative Study of Autopsy Cases between Japan and North America". The Annals of Occupational Hygiene. 2002. doi:10.1093/annhyg/46.suppl_1.265. ISSN 1475-3162.
Retrieved from "https://www.wikidoc.org/index.php?title=Caplans_syndrome_epidemiology_and_demographics&oldid=1704686"